Finance and markets: business, quotes, gold, energy and releases.
Found 42214 articles
The New York-based Rosen Law Firm is probing potential breaches of fiduciary duty by the board and executive officers at BellRing Brands, Inc. The investigation targets the conduct of company leadership, prompting a call for shareholders to come forward as the firm evaluates a possible legal challenge.
Investors who purchased Hertz Global Holdings common stock between May 7 and June 23, 2026, have until September 22 to move the court for lead plaintiff status. The Rosen Law Firm is spearheading the litigation, alleging the company misled shareholders regarding its liquidity and the impact of the used-car market.
Ventilation manufacturer Systemair has published its 2025/26 sustainability statement, detailing a 10 percent reduction in Scope 1 and 2 emissions and a significant drop in workplace injuries. The report marks the company's first submission under the Corporate Sustainability Reporting Directive, reflecting a shift toward stricter environmental and social governance.
San Francisco-based Animotion Robotics has unveiled Éloi, a bionic entity designed for human coexistence rather than utilitarian labor. Departing from the industry standard of task-oriented automation, the robot features a proprietary cognitive core that grants it the agency to pause, remain silent, or express fatigue based on its own internal state.
When a 7.8-magnitude earthquake devastated northern Pakistan in 2005, it claimed 73,000 lives and left a generation of engineers determined to prevent future catastrophes. Today, that trauma drives the China-Pakistan Belt and Road Joint Laboratory, where researchers use AI and big data to fortify infrastructure against natural disasters.
Shares of AstraZeneca slid 5.7% last month after the pharmaceutical giant revealed its experimental heart treatment, Wainua, missed key clinical targets. Now, the New York-based Pomerantz Law Firm is probing whether the company’s leadership misled stakeholders regarding the viability of the late-stage Phase-3 CARDIO-TTransform trial.
A sharp 23.9% drop in Zevra Therapeutics stock has triggered a formal investigation by Pomerantz LLP. The inquiry centers on potential securities fraud following the European Medicines Agency's rejection of the company's application for its lead drug candidate, arimoclomol, intended to treat Niemann-Pick disease type C.
A 17.6% drop in Celcuity Inc. shares following the company's delayed commercial launch announcement has triggered a formal investigation by Pomerantz LLP. The firm is now examining whether the breast cancer therapy developer and its leadership engaged in securities fraud or unlawful business practices during the lead-up to the regulatory approval.
A 6.74 percent drop in Agios Pharmaceuticals’ share price has triggered a formal investigation by Pomerantz LLP. The firm is examining potential securities fraud and unlawful business practices after the company abandoned the development of its oral pyruvate kinase activator, tebapivat, citing lackluster results from a recent Phase 2 trial.
Pathward Financial faces a formal investigation by Pomerantz LLP following a fiscal third-quarter report that revealed a sharp spike in nonperforming loans. The probe centers on potential securities fraud or unlawful business practices after the company missed earnings expectations and slashed its full-year guidance, triggering a significant drop in share value.
A 9% slide in Noble Corporation shares has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The inquiry follows the company’s July 27 disclosure of a $43 million financial hit stemming from rig suspensions in Brazil and a subsequent downgrade of its full-year EBITDA guidance.
A 25.21% plummet in IBM stock on July 14, 2026, has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The firm is examining whether company leadership misled shareholders after a series of failed large deals and a significant shortfall in transaction processing performance crippled quarterly results.
Allegations of systematically misclassified expenses have triggered a probe into Alignment Healthcare, targeting potential securities fraud after a whistleblower complaint surfaced in July. The investigation centers on claims that the company inflated financial performance metrics, including Adjusted EBITDA, to distort its reported results and executive compensation.
A 7.84% drop in share price followed Americold Realty Trust’s July 23 announcement that it would terminate major distribution agreements in Pennsylvania and Connecticut. The sudden disclosure of an expected $305 million to $320 million non-cash impairment charge has prompted Pomerantz LLP to launch an investigation into potential securities fraud.
A sharp drop in share price following a disclosure of significant credit losses has triggered an investigation by Pomerantz LLP into FirstSun Capital Bancorp. The firm is examining whether company leadership engaged in unlawful business practices or securities fraud, potentially affecting shareholder value after a July 9 announcement.
A 12.65% drop in AppLovin Corporation’s share price has triggered a formal investigation by Pomerantz LLP. The firm is scrutinizing whether company leadership engaged in securities fraud or unlawful business practices, specifically centering on the performance of the tech firm’s recently launched AI-driven merchant platform.
A 21 percent drop in Karyopharm Therapeutics stock following the disclosure of executive retention bonuses has triggered a formal investigation by Pomerantz LLP. The law firm is currently scrutinizing whether the company’s leadership engaged in securities fraud or unlawful business practices regarding these multimillion-dollar compensation packages.
A 12.38% single-day stock drop followed by a 22.51% slide has triggered a formal investigation into Wheels Up Experience Inc. New York-based law firm Pomerantz LLP is now probing whether the company’s leadership misled investors or engaged in unlawful business practices regarding its financial reporting and recent corporate restructuring.
Ionis Pharmaceuticals shares plummeted 23.9% on July 9, 2026, after the company revealed its late-stage CARDIO-TTransform trial for the amyloid cardiomyopathy treatment Wainua failed to hit its primary endpoint. The stock dropped $20.19 to close at $64.27, triggering a formal inquiry by the law firm Pomerantz LLP.
A 12 percent stock drop following a January downgrade has triggered a formal investigation into AST SpaceMobile. New York-based Pomerantz LLP is now examining whether the company or its executives engaged in securities fraud, seeking to represent investors who suffered losses amid mounting competition and financial volatility.
A 21.63% single-day collapse in stock value has triggered a formal investigation into Albertsons Companies, Inc. New York-based Pomerantz LLP is probing potential securities fraud and unlawful business practices following the retailer's failure to meet consensus earnings expectations and a subsequent downward revision of its full-year financial outlook.
A 21% single-day stock plunge following weak second-quarter results has triggered a formal investigation into Lennox International. New York-based Pomerantz LLP is now scrutinizing the climate surrounding the company’s financial disclosures, probing whether officers or directors misled shareholders regarding the firm's true performance and market outlook.
Coastal Financial Corporation shares plummeted over 43% following a $42.1 million quarterly loss, prompting New York-based Pomerantz LLP to open an investigation into potential securities fraud. The inquiry centers on whether leadership misled shareholders regarding the financial stability of the company's CCBX consumer loan portfolio.
A sharp 16.51% drop in Olin Corporation's stock price following a disastrous plant shutdown has triggered a formal investigation by Pomerantz LLP. The firm is scrutinizing whether the chemical manufacturer and its leadership engaged in securities fraud or unlawful business practices that harmed shareholders during the second quarter.
Two deaths linked to a cyclosporiasis outbreak traced to iceberg lettuce at Taco Bell locations have triggered a securities fraud investigation into Yum! Brands. The probe examines whether company leadership misrepresented business practices, following a 2.92% drop in the firm’s stock price after the health crisis was made public.
A 17 percent single-day plunge in Vertiv Holdings stock has triggered a formal investigation by the New York-based Pomerantz law firm. Attorneys are currently scrutinizing whether the company’s leadership committed securities fraud or engaged in unlawful business practices following a significant earnings miss reported in late July.
Teladoc Health shares plummeted nearly 40 percent in late July after the company slashed its full-year revenue outlook, citing deep-seated struggles within its BetterHelp platform. The sudden downward revision has now triggered a formal investigation by the New York-based Pomerantz Law Firm into potential securities fraud.
Starting August 2026, Trip.com Group will implement a mandatory 20-day paid paternity leave policy across its global operations. This commitment anchors the company's 2025 Sustainability Report, which details a new USD 100 million innovation fund and validated net-zero emissions targets for the travel giant.
DoubleVerify shareholders face a critical assessment of their company's pending $2.15 billion acquisition by Nielsen, as Milwaukee-based law firm Ademi LLP investigates whether the board failed to secure a fair valuation for public investors during the all-cash transaction.
Investor rights firm Halper Sadeh LLC is scrutinizing three corporate transactions, alleging potential breaches of fiduciary duty and securities law violations. The investigations target the acquisitions of Utz Brands, Twin Vee PowerCats, and Crinetics Pharmaceuticals, questioning whether shareholders are receiving fair value and if deal terms unfairly stifle competing offers.